Authors


Jacob A. Rogers

Latest:

Study compares postoperative refractive accuracy of formula-modified keratometry values versus total keratometry values obtained by a swept-source OCT biometer with new-generation multivariable IOL calculation formulas

Older generation non-LVC formulas show marked improvement upon using TK values vs K, while multivariable non-LVC formulas did not consistently improve.


Jella An, MD

Latest:

Netarsudil provides IOP lowering in goniotomy treated eyes

The unique MOA may deliver a synergistic effect when prescribed post-surgically.


Jeremiah Brown Jr, MD

Latest:

Shifting paradigm in GA management means focusing attention on imaging

Ophthalmologists can use OCT to find the early signs of disease


Andrew R. Harrison, MD

Latest:

Advancement in TED treatment is a bright spot

FDA approval of teprotumumab as therapeutic offers hope for patients.


Gerald J. Roper, MD

Latest:

Protecting cataract patients and their surgeons' practices

Maximizing refractive surgery is key to ensuring prosperous future


Steven A. Greenstein, MD

Latest:

IKA Keratoconus Symposium 2023: New data presented for epi-on cross-linking

John D. Gelles, OD, and Steven A. Greenstein, MD, share some insights into the new data on corneal cross-linking presented at IKA Keratoconus Symposium.


Colin R. Green, PhD, DSc

Latest:

Innovation Series: What a noninvasive eye drop approach may mean for the future of keratoconus

Ehsan Sadri, MD, FACS, of Visionary Eye Institute in Newport Beach, California, sat down with Professor Emeritus Colin R. Green, PhD, DSc, University of Auckland, in Auckland, New Zealand, to learn more about a novel therapy in development for the treatment of keratoconus and other corneal ectasias.


Bonnie An Henderson, MD

Latest:

AAO 2024: Enhancing the paradigm of 'see one, do one, teach one' with technology

Bonnie An Henderson, MD, highlights the importance of diverse learning methods and continuous education for clinicians in the Kelman Lecture.



Sydney M Crago

Latest:

AAO 2024: Suprachoroidal drug delivery in the real world

Glenn C. Yiu, MD, PhD, from the University of California David, shared insights from his presentation on suprachoroidal drug delivery in the real world at this year's AAO meeting held in Chicago, Illinois.


S.K. Steven Houston III, MD, FASRS

Latest:

Welcome to the metaverse: Technology allows ophthalmologists to mingle with colleagues worldwide

Answers to common questions that can help kick-start the journey into the metaverse to learn from the many virtual educational meetings and conference opportunities while mingling with colleagues worldwide.


Nancy Holekamp, MD

Latest:

ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTS

Considerations in the treatment of diabetic retinopathy and diabetic macular edema.


Marco Mura, MD

Latest:

Managing neovascular retinal disease in COVID-19 era requires careful approach

Minimizing clinic visits, maximizing use of imaging modalities are key.


Karl Stonecipher, MD

Latest:

Final Pearls on Managing Dry Eye Patients With Comorbidities

Ophthalmologists end their discussion on the management of dry eye disease with other ocular comorbidities highlighting key takeaways and prospective advances in care and outcomes.


Mark T. Dunbar, OD, FAAO

Latest:

ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTS

Considerations in the treatment of diabetic retinopathy and diabetic macular edema.


Samir N. Patel, MD

Latest:

Focusing on postinjection endophthalmitis

Systemic immunosuppression may prevent devastating complication in patients.



Victor H. Gonzalez, MD

Latest:

Seize underutilized opportunity to treat glaucoma during vitrectomy

Ophthalmologists can reduce IOP and medications with endocyclophotocoagulation while in the eye.


Marta Ibarz Barberá, MD

Latest:

Benefits of topography-guided treatments for irregular corneas

Procedure can improve best-corrected visual acuity, enhancing quality of life for patients.


Frank Joseph Goes, MD

Latest:

Inherited retinal diseases meet their therapeutic match

The retina is a key proving ground for long-held theories of genetics.


Marina Roizenblatt, MD, PhD

Latest:

The evolving role of vitreosurgical simulators in surgical training

Need to eliminate errors results in optimization of training of novice surgeons.


Carl D. Regillo, MD, FACS, FASRS

Latest:

Considerations for the Future of Biosimilars in the Treatment of Retinal Disorders

Carl D. Regillo, MD, and Jennifer I. Lim, MD, emphasize the high regulatory standards of equivalence and safety of biosimilars in considering the role they will play in the evolving treatment landscape for retinal disorders.


Dilraj S. Grewal, MD

Latest:

Weighing treatments for chronic postop cystoid macular edema

Prompt and adequate action is a key to facilitating the best recovery in patients.


Kassi Jackson

Latest:

FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasis

Ocuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents.


Gary W. Jerkins, MD

Latest:

Increasing your practice’s reach, relevance, and revenue with clinical trials

Working as an investigator can prove to be a positive experience for physicians


Kamran M. Riaz, MD

Latest:

Mixing and Matching Monofocal Plus IOLs with Other Advanced Technology IOLs

Kamran Riaz, MD, reviews a cataract surgery case where the patient was fitted with different IOLs in each eye.


Rahul T. Pandit, MD

Latest:

The eyes offer conjunctival clue to COVID-19

A patient's vision loss leads to another diagnosis


Livia George, BS

Latest:

Unlocking health mysteries

Researchers find a strong link between Alzheimer's disease and retinal thinning


Neda Shamie, MD

Latest:

CIME 2024: Neda Shamie, MD, recaps a morning session packed with refractive surgery options, retina, glaucoma, and a 'mite-y' Demodex discussion

The 18th annual Controversies in Modern Eye Care conference, held on May 4, 2024, in Los Angeles, was co-chaired by Neda Shamie, MD, and Arjan Hura, MD, with the aim of discussing the latest advancements in eye care.


Douglas Rhee, MD

Latest:

From waste to wonder: Transformational advances in scleral allograft technology

Unlocking the potential of donor scleral tissue: Innovations and future applications.

© 2024 MJH Life Sciences

All rights reserved.